SCHEMBL622960

SCHEMBL622960

CC(O)CC(O)C(O)CCCO

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.37
TRPA1 O75762 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
PTPN1 P18031 1/20 0.33
SPHK1 Q9NYA1 2/20 0.32
TSHR P16473 1/20 0.30
CYP2D6 P10635 2/20 0.30
GMNN O75496 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
THPO P40225 1/20 0.30
MTOR P42345 1/20 0.30
BLM P54132 1/20 0.30
KDM4E B2RXH2 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
CETP P11597 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16460136 0.95 TRPV1 (0.34) TRPV1TRPA1TDP1PTPN1SPHK1
SCHEMBL6423646 0.93 TRPV1 (0.41) TRPV1TRPA1TDP1PTPN1SPHK1
SCHEMBL15484184 0.84 TDP1 (0.40) TRPA1TDP1TSHR
SCHEMBL13447458 0.84 TDP1 (0.40) TRPA1TDP1TSHR
SCHEMBL7870407 0.81 TSHR (0.42) TRPV1TRPA1TDP1PTPN1SPHK1
SCHEMBL1687120 0.81 THRB (0.37) TRPV1TRPA1TDP1PTPN1SPHK1
SCHEMBL16078672 0.80 SPHK1 (0.46) TRPV1TRPA1SPHK1TSHRCYP2D6
SCHEMBL17686274 0.79 TDP1 (0.40) TDP1TSHR
SCHEMBL29876881 0.78 TSHR (0.47) TRPV1TRPA1TDP1TSHRLMNA
SCHEMBL7847549 0.77 TDP1 (0.38) TRPA1TDP1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129292-A1 FORMULATION FOR SUBSTITUTED 2-AMINOTHIAZOLES IN THE TREATMENT OF FUNGAL AND FUNGAL-BACTERIAL INFECTIONS OF THE NAIL OnychoPharm GmbH (DE) 2023-02-08 EP claimed
US-20160194574-A1 SEGMENTED COPOLYMER COMPOSITIONS AND COATINGS INCORPORATING THESE COMPOSITIONS HRL LABORATORIES, LLC 2016-07-07 US claimed
EP-1706411-B1 METHOD FOR PREPARING PHTHALOCYANINES BASF SE (DE) 2010-02-24 EP claimed
US-20070047095-A1 Electrowetting system with stable movement SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) 2007-03-01 US claimed
EP-1350809-B1 Water insoluble porogen removal process ROHM & HAAS (US) 2006-06-07 EP claimed
US-6900360-B2 Condensation of acetaldehyde; hydrogenation DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2005-05-31 US claimed
EP-1350809-A1 Water insoluble porogen removal process ROHM AND HAAS COMPANY (US) 2003-10-08 EP claimed
CN-111777519-B Diamines 日产化学工业株式会社 2023-12-05 CN disclosed
EP-3131754-B1 WEATHERABLE FIRST SURFACE OVER A TIE LAYER OVER A PULTRUDED SUBSTRATE TRINSEO EUROPE GMBH (CH) 2023-08-23 EP disclosed
CN-111971617-B Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same 日产化学株式会社 2023-06-20 CN disclosed
US-11596150-B2 Long chain glycolipids useful to avoid perishing or microbial contamination of materials IMD NATURAL SOLUTIONS GMB (DE) 2023-03-07 US disclosed
EP-4129292-A1 FORMULATION FOR SUBSTITUTED 2-AMINOTHIAZOLES IN THE TREATMENT OF FUNGAL AND FUNGAL-BACTERIAL INFECTIONS OF THE NAIL OnychoPharm GmbH (DE) 2023-02-08 EP disclosed
CN-110049971-B Diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element 日产化学株式会社(JP) 2023-01-13 CN disclosed
US-5168110-A POWDER COATING BASED ON A CARBOXYL-FUNCTIONAL POLYESTER AND AN EPOXY-FUNCTIONAL CROSS-LINKING AGENT DSM N.V. of Het Overloon (NL) 1992-12-01 US disclosed
US-5064486-A COLLOIDAL POLYMER DISPERSION FOR INTERNAL SEALING OF PIPES AND PROCESS FOR THE APPLICATION THEREOF SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1991-11-12 US disclosed
CN-1055281-A A kind of high-effective disinfecting, bactericidal agent and preparation method thereof FAN ZHONG (CN) 1991-10-16 CN disclosed
EP-0442583-A1 Powder coating based on a carboxyl-functional polyester and an epoxy-functional cross-linking agent DSM N.V. (NL) 1991-08-21 EP disclosed
EP-0410714-A1 Non-tacky composit resin composition and process for the preparation thereof NIPPON POLYURETHANE INDUSTRY CO. LTD. (JP) 1991-01-30 EP disclosed
WO-1989011497-A1 THERMOSET DRAWABLE COATING COMPOSITIONS PPG INDUSTRIES, INC. (US) 1989-11-30 WO disclosed
US-4792574-A Stable, low viscosity polymer/polyisocyanate dispersion made using a macromolecular monomer and a functional monomer OLIN CORPORATION (US) 1988-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11596150-B2 Long chain glycolipids useful to avoid perishing or microbial contamination of materials LPO, PLIN1, PLIN3 TRPV1 532/4885TRPA1 1030/4885TDP1 4300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.